Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1909 1
1967 1
1969 1
1971 2
1975 6
1976 4
1977 1
1978 2
1980 5
1981 4
1982 4
1983 4
1984 7
1985 10
1986 9
1987 6
1988 12
1989 15
1990 17
1991 17
1992 38
1993 49
1994 44
1995 36
1996 50
1997 53
1998 80
1999 88
2000 79
2001 87
2002 99
2003 102
2004 114
2005 109
2006 145
2007 129
2008 137
2009 176
2010 214
2011 243
2012 249
2013 258
2014 293
2015 330
2016 336
2017 308
2018 365
2019 386
2020 463
2021 488
2022 521
2023 480
2024 209

Text availability

Article attribute

Article type

Publication date

Search Results

6,182 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for setting cf
Search for Bettina CF instead (1 results)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. Albert MS, et al. Alzheimers Dement. 2011 May;7(3):270-9. doi: 10.1016/j.jalz.2011.03.008. Epub 2011 Apr 21. Alzheimers Dement. 2011. PMID: 21514249 Free PMC article.
The workgroup developed the following two sets of criteria: (1) core clinical criteria that could be used by healthcare providers without access to advanced imaging techniques or cerebrospinal fluid analysis, and (2) research criteria that could be used in clinical …
The workgroup developed the following two sets of criteria: (1) core clinical criteria that could be used by healthcare providers without ac …
Neurofilament light chain as a biomarker in neurological disorders.
Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H. Gaetani L, et al. J Neurol Neurosurg Psychiatry. 2019 Aug;90(8):870-881. doi: 10.1136/jnnp-2018-320106. Epub 2019 Apr 9. J Neurol Neurosurg Psychiatry. 2019. PMID: 30967444 Review.
Neurofilament light chain (NfL) is a neuronal cytoplasmic protein highly expressed in large calibre myelinated axons. Its levels increase in cerebrospinal fluid (CSF) and blood proportionally to the degree of axonal damage in a variety of neurological disorders, inc …
Neurofilament light chain (NfL) is a neuronal cytoplasmic protein highly expressed in large calibre myelinated axons. Its levels increase in …
Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias.
Baiardi S, Quadalti C, Mammana A, Dellavalle S, Zenesini C, Sambati L, Pantieri R, Polischi B, Romano L, Suffritti M, Bentivenga GM, Randi V, Stanzani-Maserati M, Capellari S, Parchi P. Baiardi S, et al. Alzheimers Res Ther. 2022 Oct 12;14(1):153. doi: 10.1186/s13195-022-01093-6. Alzheimers Res Ther. 2022. PMID: 36221099 Free PMC article.
However, confirmatory studies are required to demonstrate their usefulness in the clinical setting. METHODS: We evaluated plasma and cerebrospinal fluid (CSF) samples from consecutive patients with frontotemporal dementia (FTD) (n = 59), progressive supranucl …
However, confirmatory studies are required to demonstrate their usefulness in the clinical setting. METHODS: We evaluated plasma and …
Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid.
Miller S, Naccache SN, Samayoa E, Messacar K, Arevalo S, Federman S, Stryke D, Pham E, Fung B, Bolosky WJ, Ingebrigtsen D, Lorizio W, Paff SM, Leake JA, Pesano R, DeBiasi R, Dominguez S, Chiu CY. Miller S, et al. Genome Res. 2019 May;29(5):831-842. doi: 10.1101/gr.238170.118. Epub 2019 Apr 16. Genome Res. 2019. PMID: 30992304 Free PMC article.
Metagenomic next-generation sequencing (mNGS) for pan-pathogen detection has been successfully tested in proof-of-concept case studies in patients with acute illness of unknown etiology but to date has been largely confined to research settings. Here, we developed and vali …
Metagenomic next-generation sequencing (mNGS) for pan-pathogen detection has been successfully tested in proof-of-concept case studies in pa …
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.
Vermunt L, Sikkes SAM, van den Hout A, Handels R, Bos I, van der Flier WM, Kern S, Ousset PJ, Maruff P, Skoog I, Verhey FRJ, Freund-Levi Y, Tsolaki M, Wallin ÅK, Olde Rikkert M, Soininen H, Spiru L, Zetterberg H, Blennow K, Scheltens P, Muniz-Terrera G, Visser PJ; Alzheimer Disease Neuroimaging Initiative; AIBL Research Group; ICTUS/DSA study groups. Vermunt L, et al. Alzheimers Dement. 2019 Jul;15(7):888-898. doi: 10.1016/j.jalz.2019.04.001. Epub 2019 Jun 1. Alzheimers Dement. 2019. PMID: 31164314 Free PMC article.
INTRODUCTION: We estimated the age-specific duration of the preclinical, prodromal, and dementia stages of Alzheimer's disease (AD) and the influence of sex, setting, apolipoprotein E (APOE) genotype, and cerebrospinal fluid tau on disease duration. ...DISCUS …
INTRODUCTION: We estimated the age-specific duration of the preclinical, prodromal, and dementia stages of Alzheimer's disease (AD) and the …
Biomarkers for tau pathology.
Schöll M, Maass A, Mattsson N, Ashton NJ, Blennow K, Zetterberg H, Jagust W. Schöll M, et al. Mol Cell Neurosci. 2019 Jun;97:18-33. doi: 10.1016/j.mcn.2018.12.001. Epub 2018 Dec 7. Mol Cell Neurosci. 2019. PMID: 30529601 Free PMC article. Review.
A keystone in the diagnosis of tauopathies was the development of methods to assess levels of tau protein in vivo in cerebrospinal fluid, which has significantly improved our knowledge about these conditions. ...The recent addition of positron emission tomography li …
A keystone in the diagnosis of tauopathies was the development of methods to assess levels of tau protein in vivo in cerebrospinal …
Xanthochromia.
Edlow JA, Bruner KS, Horowitz GL. Edlow JA, et al. Arch Pathol Lab Med. 2002 Apr;126(4):413-5. doi: 10.5858/2002-126-0413-X. Arch Pathol Lab Med. 2002. PMID: 11900563 Free article.
CONTEXT: Diagnosis of subarachnoid hemorrhage is usually established by computed tomographic scanning; however, in a few patients, lumbar puncture to examine the cerebrospinal fluid for erythrocytes and xanthochromia is necessary. ...1947 (99.7%) reported using visu …
CONTEXT: Diagnosis of subarachnoid hemorrhage is usually established by computed tomographic scanning; however, in a few patients, lumbar pu …
Hydrocephalus in children.
Rizvi R, Anjum Q. Rizvi R, et al. J Pak Med Assoc. 2005 Nov;55(11):502-7. J Pak Med Assoc. 2005. PMID: 16304873 Review.
Historically it is believed to result from imbalance between CSF production and absorption, with net accumulation of fluid in the cranial cavity; characterized by increase in size of the cerebral ventricles. ...The clinical features are increase in the size of head, with w …
Historically it is believed to result from imbalance between CSF production and absorption, with net accumulation of fluid in the cra …
Associations of the A/T/N profiles in PET, CSF, and plasma biomarkers with Alzheimer's disease neuropathology at autopsy.
Wang ZB, Tan L, Gao PY, Ma YH, Fu Y, Sun Y, Yu JT; Alzheimer's Disease Neuroimaging Initiative. Wang ZB, et al. Alzheimers Dement. 2023 Oct;19(10):4421-4435. doi: 10.1002/alz.13413. Epub 2023 Jul 28. Alzheimers Dement. 2023. PMID: 37506291
INTRODUCTION: To examine the extent to which positron emission tomography (PET)-, cerebrospinal fluid (CSF)-, and plasma-related amyloid-beta/tau/neurodegeneration (A/T/N) biomarkers are associated with Alzheimer's disease (AD) neuropathology at autopsy. ...DISCUSSI …
INTRODUCTION: To examine the extent to which positron emission tomography (PET)-, cerebrospinal fluid (CSF)-, and plasma-relat …
Blood-based biomarkers in Alzheimer's disease - moving towards a new era of diagnostics.
Arslan B, Zetterberg H, Ashton NJ. Arslan B, et al. Clin Chem Lab Med. 2024 Jan 23;62(6):1063-1069. doi: 10.1515/cclm-2023-1434. Print 2024 May 27. Clin Chem Lab Med. 2024. PMID: 38253262 Free article. Review.
Alzheimer's disease (AD), a primary cause of dementia globally, is traditionally diagnosed via cerebrospinal fluid (CSF) measures and positron emission tomography (PET). ...In summary, blood-based biomarkers are increasingly crucial in AD diagnosis, follow-up, progn …
Alzheimer's disease (AD), a primary cause of dementia globally, is traditionally diagnosed via cerebrospinal fluid (CSF) measu …
6,182 results